Using Biologic Medications for Autoimmune Disorders

This presentation will provide useful definitions of “biologic” and “autoimmune disorders,” focusing on those with dermatological indications and manifestations. We will list the currently-available biologics for several varieties of autoimmune skin disorders, along with their recently-approved “biosimilars,” using adalimumab (which was, until COVID-19, the best-selling drug in the USA for several years running) as the index case, and show what few data exist about head-to-head comparisons of these agents. Lastly, we will discuss drugs with similar indications for skin disorders that are not properly “biologics” (although they are priced similarly!).

Dr. Elliott's Faculty Disclosure

The Washington Osteopathic Medical Association is accredited by the American Osteopathic Association as a Category 1 CME Sponsor. 
The WOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements.
Comments, questions, or complaints should be forwarded to WOMA Executive Director, Roseanne Andersen, by calling the WOMA office at 425-677-3930, by mail to WOMA, P.O. Box 1187, Gig Harbor, WA 98332, or by email to executivedirector@woma.org.